Sudhakar Jha

7PUBLICATIONS
52CO-AUTHORS
Molecular targetsCancer geneticsEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 01, 2026
Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancers.

Jing Han Hong, Chern Han Yong, Hong Lee Heng

|Nov 02, 2023
E4F1 and ZNF148 are transcriptional activators of the -57A > C and wild-type TERT promoter.

Boon Haow Chua, Nurkaiyisah Zaal Anuar, Laure Ferry

|Jan 13, 2023
Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy.

Xue-Bin Ran, Ling-Wen Ding, Qiao-Yang Sun

|Jan 08, 2023
Epimutations and Their Effect on Chromatin Organization: Exciting Avenues for Cancer Treatment.

Asad Mohammad, Sudhakar Jha

|May 08, 2021
The oncogenic E3 ligase TRIP12 suppresses epithelial-mesenchymal transition (EMT) and mesenchymal traits through ZEB1/2.

Kwok Kin Lee, Deepa Rajagopalan, Shreshtha Sailesh Bhatia

|Jun 13, 2018
High-Risk Human Papillomaviral Oncogenes E6 and E7 Target Key Cellular Pathways to Achieve Oncogenesis.

Nicole S L Yeo-Teh, Yoshiaki Ito, Sudhakar Jha

Pageof 2

Frequent Collaborators

1 joint publications

Deepa Rajagopalan

1 joint publications

Boon Haow Chua

1 joint publications

Shreshtha Sailesh Bhatia

1 joint publications

Kwok Kin Lee